SMALL GRANT PROGRAM FOR THE NATIONAL INSTITUTE ON DEAFNESS AND OTHERCOMMUNICATION DISORDERS NIH GUIDE, Volume 22, Number 39, October 29, 1993 PA NUMBER: PAR-94-009 P.T. 34 Keywords: Communicative Disorders, Hearing Communicative Disorders, Speech Language Acquisition & Development 0775017 National Institute on Deafness and Other Communication Disorders PURPOSE This program announcement supersedes all previously issued announcements for the National Institute on Deafness and Other Communication Disorders (NIDCD) Small Grant Program. This current Small Grant Program provides support for pilot research that is likely to lead to a subsequent individual research project grant (R01) or a First Independent Research Support and Transition (FIRST) (R29) award application. The research must be focused on areas within the mission of the NIDCD, that is, hearing, balance/vestibular, smell, taste, voice, speech, or language. HEALTHY PEOPLE 2000 The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2000," a PHS-led national activity for setting priority areas. This program announcement, Small Grant Program for the NIDCD, is related to the priority area of clinical prevention services. Potential applicants may obtain a copy of "Healthy People 2000" (Full Report: Stock No. 017-001-11474-0) or "Healthy People 2000" (Summary Report: Stock No. 017-001-11473-1) through the Superintendent of Documents, Government Printing Office, Washington, DC 20402-9325 (telephone 202-783-3238). ELIGIBILITY REQUIREMENTS Foreign organizations and institutions are not eligible. Current and previous recipients of NIH research grants such as small grant awards, Career Development Awards, R01, or R29 grants are ineligible for the Small Grant program. Individuals who have received research support from other Federal funding agencies are considered ineligible. Participation in the program by investigators at minority institutions is strongly encouraged. Small grant funds may not be used to support thesis or dissertation research. MECHANISM OF SUPPORT This program announcement will use the small grant (R03) mechanism. Applicants may request up to $25,000 (direct costs) per year. The grant may not exceed two years and is not renewable. Investigators are expected to seek continuing support for research through a research project grant (R01) or FIRST (R29) award. RESEARCH OBJECTIVES The Small Grant program is designed solely to support basic and clinical scientists with limited research experience who are at the beginning stages of their research careers. STUDY POPULATIONS SPECIAL INSTRUCTIONS TO APPLICANTS REGARDING IMPLEMENTATION OF NIH POLICIES CONCERNING INCLUSION OF WOMEN AND MINORITIES IN RESEARCH STUDY POPULATIONS NIH policy is that applicants for NIH clinical research grants and cooperative agreements are required to include minorities and women in study populations so that research findings can be of benefit to all persons at risk of the disease, disorder or condition under study; special emphasis must be placed on the need for inclusion of minorities and women in studies of diseases, disorders and conditions which disproportionately affect them. This policy is intended to apply to males and females of all ages. If women or minorities are excluded or inadequately represented in clinical research, particularly in proposed population-based studies, a clear compelling rationale must be provided. The composition of the proposed study population must be described in terms of gender and racial/ethnic group. In addition, gender and racial/ethnic issues must be addressed in developing a research design and sample size appropriate for the scientific objectives of the study. This information must be included in the form PHS 398 in Section 1-4, of the Research Plan AND summarized in Section 5, Human Subjects. Applicants are urged to assess carefully the feasibility of including the broadest possible representation of minority groups. However, NIH recognizes that it may not be feasible or appropriate in all research projects to include representation of the full array of United States racial/ethnic minority populations (i.e., Native Americans [including American Indians or Alaskan Natives], Asian/Pacific Islanders, Blacks, Hispanics). The rationale for studies on single minority population groups should be provided. For the purpose of this policy, clinical research is defined as human biomedical and behavioral studies of etiology, epidemiology, prevention (and preventive strategies), diagnosis, or treatment of diseases, disorders or conditions, including but not limited to clinical trials. The usual NIH policies concerning research on human subjects also apply. Basic research or clinical studies in which human tissues cannot be identified or linked to individuals are excluded. However, every effort should be made to include human tissues from women and racial/ethnic minorities when it is important to apply the results of the study broadly, and this should be addressed by applicants. If the required information is not contained within the application, the application will be returned. Peer reviewers will address specifically whether the research plan in the application conforms to these policies. If the representation of women or minorities in a study design is inadequate to answer the scientific questions(s) addressed AND the justification for the selected study population is inadequate, it will be considered a scientific weakness or deficiency in the study design and reflected in assigning the priority score to the application. All applications for clinical research submitted to NIH are required to address these policies. NIH funding components will not award grants or cooperative agreements that do not comply with these policies. APPLICATION PROCEDURES Only one Small Grant application may be submitted by a Principal Investigator per receipt date. Applicants may not submit R01 or R29 applications on the same topic concurrently (to be considered at the same Advisory Council cycle) with the submission of a Small Grant application. The submission, review, and award schedule for the Small Grant Program is: Receipt Dates Institute Committee Council Earliest for FY94 Review Review Funding Dec 17, 1993 Feb-Mar May Jul Apr 8, 1994 Jun-Jul Oct Dec Aug 23, 1994 Oct-Nov Jan Apr Applications are to be submitted on the grant application form PHS 398 (rev. 9/91) and prepared according to the directions in the application packet, with the exceptions noted below. Application kits are available at most institutional offices of sponsored research and may be obtained from the Office of Grants Information, Division of Research Grants, National Institutes of Health, Westwood Building, Room 449, Bethesda, MD 20892, telephone 301-710-0267. On the face page of the application: Item 2a Type "Small Grant Program NIDCD". Check the "YES" box. Sections 1-4: Do not exceed a total of five pages for the following sections: specific aims, background and significance, progress report/preliminary studies, and experimental design and methods. An additional half-page introduction is acceptable only for revised applications. Applications that exceed the page limitation or NIH requirements for type size and margins will be returned to the investigator. The five page limitation does not include Sections 5-9 (Human Subjects, Consortia). Appendix materials are not allowed. Use the mailing label in the application kit to mail the original and four copies of the application to: Division of Research Grants National Institutes of Health Westwood Building, Room 240 Bethesda, MD 20892** To ensure that the application is received in sufficient time for the review, send one copy of the application to: Chief, Scientific Review Branch National Institute on Deafness and Other Communication Disorders Executive Plaza South, Room 400-C 6120 Executive Boulevard Bethesda, MD 20892 REVIEW CONSIDERATIONS A review committee of the NIDCD will evaluate each Small Grant application in accordance with the usual NIH peer review procedures and criteria. Applications will be evaluated with respect to the following criteria: o Scientific, technical, or clinical significance and originality of the proposed research. o Appropriateness and adequacy of the experimental approach and methodology proposed to carry out the research. o Appropriateness of the statistical methods proposed to analyze the results. o Potential of the proposed studies to lead to more extensive research. o Qualifications and research experience of the principal investigator. o Availability of resources necessary for the research, including any needed to supplement the budget. o Appropriateness of the proposed budget and timetable in relation to the scope of the proposed research. o The adequacy of the proposed means for protecting against or minimizing potential adverse effects upon humans, animals, or the environment. o Adequacy of adherence to guidelines for including gender and minority representation in any study population. All applications subsequently will be reviewed by the National Deafness and Other Communication Disorders Advisory Council. AWARD CRITERIA The award of grants is contingent on (1) receipt of applications of high scientific merit; (2) responsiveness to this announcement, including the eligibility of investigators; (3) relevance to the mission of NIDCD; and (4) the availability of appropriated funds. INQUIRIES For additional information, investigators are encouraged to call or write to NIDCD staff responsible for grants in the investigator's particular area of scientific interest: Dr. Kenneth Gruber Hearing (301) 402-3458 Dr. Daniel Sklare Balance/Vestibular (301) 496-1804 Dr. Jack Pearl Smell/Taste (301) 402-3464 Dr. Rochelle Small Smell/Taste (301) 402-3464 Dr. Beth Ansel Voice/Speech (301) 402-3461 Dr. Judith Cooper Language (301) 496-5061 For budgetary and fiscal questions, contact: Grants Management Officer National Institute on Deafness and Other Communication Disorders Executive Plaza South, Room 400-C 6120 Executive Boulevard Bethesda, MD 20892 Telephone: (301) 402-0909 AUTHORITY AND REGULATIONS Awards will be made under the authority of the Public Health Service Act, Section 301 (Public Law 78-410, as amended; 42 USC 241) and administered under PHS grants policies and Federal Regulations 42 CFR Part 52 and 45 CFR Part 74. The program is not subject to the intergovernmental review requirements of Executive Order 12372 or to Health Systems Agency review. .
Return to NIH Guide Main Index
![]() |
Office of Extramural Research (OER) |
![]() |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
![]() |
Department of Health and Human Services (HHS) |
![]() |
||||